Indian Indices
Global Indices
Commodity (SPOT)
Currency (SPOT)
09 Dec 2016 | 4:41 AM
 

Marksans Pharma Ltd. Share Price Live (BSE)
0

BSE Code: 524404 | NSE Symbol: MARKSANS
43.25
0.20
(0.47 %)
08 Dec 2016 | 04:01 PM
Change company
  • Open (Rs)
    43.25
  • Prev. close (Rs.)
    43.05
  • High (Rs.)
    43.75
  • Low (Rs.)
    43.15
  • 52W H (Rs.)
    113.80
  • 52W L (Rs.)
    33.46
  • Volume (Rs.)
    148747
  • MCap (Rs in Cr.)
    1,770.29
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
1.92
Operating Margin (%)
15.25
Gross Profit Margin (%)
12.10
Net Profit Margin (%)
8.78
Total Debt/Equity
0.20
Dividend payout Ratio (Net Profit)
22.87
Earning Retention Ratio
78.30

News

18 Oct 2016 - 14:59:00-Marksans Pharma Ltd an Indian pharma firm having global footprint on Tuesday said it has received ap...
26 Sep 2016 - 12:42:00-Shares of Marksans Pharma rallied over 12 per cent on the Bombay Stock Exchange after the drug maker...
26 Sep 2016 - 11:04:00-Leading pharma major Marksans Pharma Limited has said that USFDA has granted approval for an Abbrev...
02 May 2016 - 18:05:00-Marksans Pharma Ltd today said it has received the approval from the US health regulator for its Met...

Announcements

12-Nov-2016
Marksans Pharma - Announces Q2 results (Standalone & Consolidated) & Limited Review Report (Standalone & Consolidated) for th
12-Nov-2016
Marksans Pharma - Results Press Release for September 30 2016
12-Nov-2016
Marksans Pharma Ltd. - Press Release
04-Nov-2016
Marksans Pharma - Q2 results on Nov 12 2016
19-Oct-2016
Marksans Pharma - Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations 2015 for Quarter ended Septemb

Religare Research

08 Dec 2016 | 09:42 AM
• Gold rose from lows ahead of central bank meetings. • Oil prices fell on doubts output cut will en...
08 Dec 2016 | 07:00 AM
We have been maintaining our cautious stance on market and especially on the banking pack for last t...
07 Dec 2016 | 11:37 AM
Agri Technical report
07 Dec 2016 | 11:36 AM
Agri Fundamental report

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
6,68,725 6.05 22.45 -2.90
6,68,725 6.05 30.84 -2.90
6,68,725 6.05 32.11 -2.89
6,68,725 6.05 23.49 -2.89

Shareholding Pattern

       
Promotors48.25%
Mutual Funds/UTI0.00%
FI/Banks5.02%
Insurance5.02%
FII10.52%
Government0.00%
Others7.29%

Peer Group

Company Intraday Graph
 Neuland Laboratories Ltd.
1,018.00(-0.08)
3578
 Kovai Medical Center and Hospital Ltd.
1,000.00(-0.41)
11816
 Merck Ltd.
985.00(-0.11)
3302
 AstraZeneca Pharma India Ltd.
937.65(-0.76)
3274

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Marksans Pharma Ltd.-3.60-1.85-0.10
NIFTY(S&P CNX)-296.70-705.65-26.20
BSE SENSEX-896.86-2,351.00-326.38
BSE 500-440.48-869.18296.02

Corporate Details

Key Personal
Balwant S Desai
Whole Time Director
Mark Saldanha
Chairman & Managing Director
Sandra Saldanha
Whole Time Director
Key Address
Registered Office
11th Floor Grandeur Veera Desai Extension Road Oshiwara Andheri (West),Mumbai,Maharashtra

Tel:022-40012000, Fax:022-40012011

info@marksanspharma.com
http://www.marksanspharma.com
Registrar Office
Bigshare Services Pvt. Ltd.
Add. :E-2 & 3 Ansa Industrial Estate Saki-Vihar Road Sakinaka Andheri East

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Marksans Pharma Ltd. that will help you decide whether to buy, sell or hold Marksans Pharma Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Marksans Pharma Ltd.

Regenerate OTP
Thank You for your interest in Religare Online. Our Representative will get in touch with you shortly.